Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects
Phase 1
Completed
- Conditions
- Chronic Insomnia Characterized
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06890715
- Locations
- 🇨🇳
clinical trial centre of Medical ethics committee of Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-09-10
- Last Posted Date
- 2024-09-10
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06589921
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-09-09
- Last Posted Date
- 2024-09-09
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06588517
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2024-08-26
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT06569381
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.
Phase 1
Not yet recruiting
- Conditions
- Epilepsy
- Interventions
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05788159
- Locations
- 🇨🇳
Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China
Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition
Phase 1
Not yet recruiting
- Conditions
- InsomniaPain
- Interventions
- Drug: Compound ibuprofen polyrelease tablets
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-02-15
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05729555
- Locations
- 🇨🇳
Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions
Phase 1
Not yet recruiting
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2022-12-29
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05667818
- Locations
- 🇨🇳
Zhujiang Hospital of Southern Medical University, Guangdong, Guangzhou, China
An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.
Phase 1
Active, not recruiting
- Conditions
- Partial Seizure
- Interventions
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT05622370
- Locations
- 🇨🇳
Tianjin Municipal People's Hospital, Tianjin, Tianjin, China
Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study
Phase 1
Active, not recruiting
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT05614037
- Locations
- 🇨🇳
Clinical Trial Centre of Dongguan Kanghua Hospital, Dongguan, Guangdong, China
To Evaluate the Food Effect and the Absorption Profile of Ibuprofen Modified-Release Tablets 800 mg
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2022-04-15
- Lead Sponsor
- Overseas Pharmaceuticals, Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT05329454
- Locations
- 🇨🇳
Taipei Medical University Hospital, Taiwan, China
© Copyright 2025. All Rights Reserved by MedPath